Fosaprepitant recalls

The FDA has published 3 recalls involving Fosaprepitant since 2019. The latest was reported on 31 Jan 2024. Most were for sterility. BE Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 31 Jan 2024

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why fosaprepitant is recalled

Sterility267%
Labeling Errors133%

Companies

By year

2024133%
2020133%
2019133%

All fosaprepitant recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
31 Jan 2024Drug	CLASS II	Fosaprepitant for Injection 150 mg per vial recalledFosaprepitant	BE Pharmaceuticals	Sterility	Nationwide
22 Jul 2020Drug	CLASS III	Fosaprepitant for Injection, 150 mg / vial in a Single-Dose vial recalledFosaprepitant	Fresenius Kabi USA	Labeling Errors	Nationwide
21 Aug 2019Drug	CLASS II	Fosaprepitant 150 mg/ NS Ivpb recalled by Infusion Options	Infusion Options	Sterility	NY

Should you stop taking Fosaprepitant?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.